SCHEMBL26837665

SCHEMBL26837665

C=CC(=O)Nc1cc(-c2cccc(CC)c2)nn1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.43
▸ POLB P06746 2/20 0.43
▸ GPR142 Q7Z601 2/20 0.42
▸ EGFR P00533 1/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ JAK3 P52333 3/20 0.41
▸ JAK2 O60674 2/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CDK7 P50613 1/20 0.39
▸ CCNH P51946 1/20 0.39
▸ MNAT1 P51948 1/20 0.39
▸ GSTO1 P78417 2/20 0.39
▸ BCL2 P10415 1/20 0.39
▸ ENPP2 Q13822 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26837678 0.76 EGFR (0.42) EGFRJAK3JAK2CDK7CCNH
SCHEMBL21808407 0.74 CDK2 (0.42) MAPTPOLBGPR142EGFRRAB9A
SCHEMBL21808408 0.74 CDK2 (0.42) MAPTPOLBGPR142EGFRRAB9A
SCHEMBL25646028 0.74 IDO1 (0.48) POLBSMN1; SMN2BCL2
SCHEMBL26835187 0.72 TEK (0.55) EGFRCDK7CCNHMNAT1BCL2
SCHEMBL30935156 0.72 TGM2 (0.53) EGFRJAK3JAK2JAK1
SCHEMBL18808346 0.72 EGFR (0.63) MAPTEGFRRAB9AJAK3JAK1
SCHEMBL22895557 0.67 CCNK (0.47) EGFRSMN1; SMN2GSTO1
SCHEMBL13181426 0.67 TGM2 (0.53) MAPTPOLBEGFR
SCHEMBL15656086 0.67 MAPT (0.64) MAPTPOLBGPR142RAB9AXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3853225-B1 N-(5-(3-(1-((THIAZOL-2-YL)AMINO)-1-OXOPROPAN-2-YL)PHENYL)PYRIDIN-2-YL)ACRYLAMIDE DERIVATIVES AS CDK7 INHIBITORS FOR THE TREATMENT OF CANCER YUNGJIN PHARMACEUTICAL CO LTD (KR) 2023-11-29 — — EP disclosed
Send feedback